Used in pharmaceutical research as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in the development of anticancer agents. Its structure supports binding to enzyme active sites involved in signal transduction pathways, making it valuable in designing drugs that target tumor growth and proliferation. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity of kinase inhibitors. Also utilized in the preparation of small-molecule therapeutics for treating solid tumors and hematological malignancies.